Pharming (PHAR) Operating Margin (2020 - 2025)
Historic Operating Margin for Pharming (PHAR) over the last 6 years, with Q3 2025 value amounting to 125.69%.
- Pharming's Operating Margin rose 1202000.0% to 125.69% in Q3 2025 from the same period last year, while for Sep 2025 it was 3.04%, marking a year-over-year increase of 138900.0%. This contributed to the annual value of 2.9% for FY2024, which is 7000.0% down from last year.
- Latest data reveals that Pharming reported Operating Margin of 125.69% as of Q3 2025, which was up 1202000.0% from 2.21% recorded in Q2 2025.
- Over the past 5 years, Pharming's Operating Margin peaked at 125.69% during Q3 2025, and registered a low of 29.35% during Q1 2024.
- Moreover, its 5-year median value for Operating Margin was 2.21% (2025), whereas its average is 7.87%.
- Its Operating Margin has fluctuated over the past 5 years, first plummeted by -441100bps in 2023, then soared by 1202000bps in 2025.
- Quarter analysis of 5 years shows Pharming's Operating Margin stood at 18.45% in 2021, then plummeted by -201bps to 18.68% in 2022, then soared by 64bps to 6.63% in 2023, then crashed by -40bps to 9.3% in 2024, then skyrocketed by 1451bps to 125.69% in 2025.
- Its Operating Margin stands at 125.69% for Q3 2025, versus 2.21% for Q2 2025 and 8.91% for Q1 2025.